HMD.AX ASX
HeraMED Limited
1W: -6.7%
1M: +16.7%
3M: +0.0%
YTD: +5.0%
1Y: +23.5%
3Y: -38.7%
5Y: -78.5%
A$0.04 ($0.03)
+0.00 (+0.00%)
Weekly Expected Move ±12.8%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$2M
+18.1% ▲
Capital Expenditures
$3
+0.0% ▲
5Y CAGR: -86.5%
Free Cash Flow
-$2M
+18.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$1M
-196.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$5M | -$4M | -$3M | -$3M |
| Depreciation & Amort. | $262K | $358K | $0 | $202K | $96K |
| Stock-Based Comp. | $402K | $465K | $25K | $221K | $0 |
| Change in Working Capital | $161K | -$281K | -$102K | $173K | -$359K |
| Other Non-Cash Items | -$122K | $2M | -$997K | -$2M | $579K |
| Operating Cash Flow | -$3M | -$3M | -$6M | -$5M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$82K | -$681K | -$1K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$3K | -$10K | -$653 | $0 | $0 |
| Investing Cash Flow | -$85K | -$691K | -$2K | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $2M | -$103K | -$104K | -$127K | -$46K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$117K | -$1M | $947K | -$78K | $0 |
| Financing Cash Flow | $5M | $3M | $3M | $7M | $1M |
| Net Change in Cash | $2M | -$942K | -$3M | $1M | -$1M |
| Cash End of Period | $4M | $3M | $723K | $2M | $915K |
| Free Cash Flow | -$3M | -$3M | -$6M | -$3M | -$2M |